Coupled Graph--Policy Distillation for Personalized Medication Safety in Older Adults with Multimorbidity

• URL: http://arxiv.org/abs/2608.09443v1
• Date: Mon, 10 Aug 2026 11:19:44 GMT
• Title: Coupled Graph--Policy Distillation for Personalized Medication Safety in Older Adults with Multimorbidity
• Abstract summary: ATLAS is a coupled graph--policy distillation framework for patient-adaptive medication safety.<n>GeriMedBench is an interactive benchmark that tests safety-critical information acquisition and evidence-based decision revision.
• Score: 18.025324480690752
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Large language model (LLM) agents can support medication review between clinical visits, but safe choices for older adults with multimorbidity depend on conditions, medications, and geriatric risks that users may omit. We introduce ATLAS, a coupled graph--policy distillation framework for patient-adaptive medication safety. ATLAS structures guideline evidence as a medication-safety graph. Targeted questions update the patient state and distill relevant relations into a patient-specific medication conflict graph (PMCG). A risk-first multi-agent policy uses the PMCG to screen contraindications, assess cautions and monitoring needs, identify safer alternatives, and verify the final medication plan. We also introduce GeriMedBench, an interactive benchmark that tests safety-critical information acquisition and evidence-based decision revision. Across a European non-interactive multimorbidity benchmark, an Asian interactive multimorbidity benchmark, and an Asian non-interactive cross-guideline benchmark, ATLAS achieves the strongest complete-decision performance among the compared systems. On the European non-interactive multimorbidity benchmark, it exceeds the strongest proprietary LLM baseline by 53.73 points in Strict Success Rate and 14.63 points in overall safety reasoning score (OSRS), with no unsafe recommendations under the automated evaluator. A blinded clinician evaluation gives ATLAS higher mean ratings across all five criteria and flags potentially unsafe recommendations in one ATLAS case and two Gemini cases.

Related papers

• FRAC-MAS: A Safe and Explainable Multi-Agent System for Fracture Diagnosis [0.6351973754158782]
  FRAC-MAS is an agentic AI system for automated, explainable, and safe bone fracture detection.<n>A pipeline-depth ablation study confirms that our multi-agent critic triages 86.6% of cases into a high-confidence auto-confirmed cohort.<n>Patient preference studies against Llama, MedGemma, and Gemini demonstrate significantly more comprehensible clinical reports.
  arXiv  Detail & Related papers  (2026-08-22T10:56:00Z)
• SafeRx-Agent: A Knowledge-Grounded Multi-Agent Framework for Safe and Explainable Medication Recommendation [12.70587762578296]
  We propose SafeRx-Agent, a knowledge-grounded multi-agent framework that uses patient context, external clinical knowledge, and safety verification to recommend traceable medication sets.<n> Experimental results on MIMIC-III and MIMIC-IV datasets show that SafeRx-Agent improves fine-grained medication prediction accuracy while controlling drug interactions, contraindications, and medication set size.
  arXiv  Detail & Related papers  (2026-05-27T22:15:48Z)
• CareGuardAI: Context-Aware Multi-Agent Guardrails for Clinical Safety & Hallucination Mitigation in Patient-Facing LLMs [5.437368195729715]
  CareGuardAI is a risk-aware safety framework for patient-facing medical question answering.<n>At inference time, CareGuardAI employs a multi-stage pipeline consisting of a controller agent, safety-constrained generation, and dual risk evaluation.<n>We evaluate CareGuardAI on PatientSafeBench, MedSafetyBench, and MedHallu, covering both safety and hallucination detection.
  arXiv  Detail & Related papers  (2026-04-07T10:54:57Z)
• A Decade-Scale Benchmark Evaluating LLMs' Clinical Practice Guidelines Detection and Adherence in Multi-turn Conversations [60.2076951536797]
  Large Language Models (LLMs) are increasingly deployed in healthcare scenarios.<n>It is unclear to which extend LLMs could identify and adhere to clinical guidelines during conversations.<n>CPGBench is an automated framework benchmarking the clinical guideline detection and adherence capabilities of LLMs.
  arXiv  Detail & Related papers  (2026-03-26T09:00:55Z)
• Health-ORSC-Bench: A Benchmark for Measuring Over-Refusal and Safety Completion in Health Context [82.32380418146656]
  Health-ORSC-Bench is the first large-scale benchmark designed to measure textbfOver-Refusal and textbfSafe Completion quality in healthcare.<n>Our framework uses an automated pipeline with human validation to test models at varying levels of intent ambiguity.<n>Health-ORSC-Bench provides a rigorous standard for calibrating the next generation of medical AI assistants.
  arXiv  Detail & Related papers  (2026-01-25T01:28:52Z)
• RxSafeBench: Identifying Medication Safety Issues of Large Language Models in Simulated Consultation [19.41567007880886]
  Large Language Models (LLMs) have achieved remarkable progress in diverse healthcare tasks.<n>However, research on their medication safety remains limited due to the lack of real world datasets.<n>We propose a framework that simulates and evaluates clinical consultations to systematically assess the medication safety capabilities of LLMs.
  arXiv  Detail & Related papers  (2025-11-06T12:56:34Z)
• Beyond Benchmarks: Dynamic, Automatic And Systematic Red-Teaming Agents For Trustworthy Medical Language Models [87.66870367661342]
  Large language models (LLMs) are used in AI applications in healthcare.<n>Red-teaming framework that continuously stress-test LLMs can reveal significant weaknesses in four safety-critical domains.<n>A suite of adversarial agents is applied to autonomously mutate test cases, identify/evolve unsafe-triggering strategies, and evaluate responses.<n>Our framework delivers an evolvable, scalable, and reliable safeguard for the next generation of medical AI.
  arXiv  Detail & Related papers  (2025-07-30T08:44:22Z)
• Lessons Learned from Evaluation of LLM based Multi-agents in Safer Therapy Recommendation [9.84660526673816]
  This study investigated the feasibility and value of using a Large Language Model (LLM)-based multi-agent system for safer therapy recommendations.<n>We designed a single agent and a MAS framework simulating multidisciplinary team (MDT) decision-making.<n>We compared MAS performance with single-agent approaches and real-world benchmarks.
  arXiv  Detail & Related papers  (2025-07-15T02:01:38Z)
• Medical Red Teaming Protocol of Language Models: On the Importance of User Perspectives in Healthcare Settings [48.096652370210016]
  We introduce a safety evaluation protocol tailored to the medical domain in both patient user and clinician user perspectives.<n>This is the first work to define safety evaluation criteria for medical LLMs through targeted red-teaming taking three different points of view.
  arXiv  Detail & Related papers  (2025-07-09T19:38:58Z)
• TAMA: A Human-AI Collaborative Thematic Analysis Framework Using Multi-Agent LLMs for Clinical Interviews [54.35097932763878]
  Thematic analysis (TA) is a widely used qualitative approach for uncovering latent meanings in unstructured text data.<n>Here, we propose TAMA: A Human-AI Collaborative Thematic Analysis framework using Multi-Agent LLMs for clinical interviews.<n>We demonstrate that TAMA outperforms existing LLM-assisted TA approaches, achieving higher thematic hit rate, coverage, and distinctiveness.
  arXiv  Detail & Related papers  (2025-03-26T15:58:16Z)
• LlaMADRS: Prompting Large Language Models for Interview-Based Depression Assessment [75.44934940580112]
  This study introduces LlaMADRS, a novel framework leveraging open-source Large Language Models (LLMs) to automate depression severity assessment.<n>We employ a zero-shot prompting strategy with carefully designed cues to guide the model in interpreting and scoring transcribed clinical interviews.<n>Our approach, tested on 236 real-world interviews, demonstrates strong correlations with clinician assessments.
  arXiv  Detail & Related papers  (2025-01-07T08:49:04Z)
• SDF-Bayes: Cautious Optimism in Safe Dose-Finding Clinical Trials with Drug Combinations and Heterogeneous Patient Groups [84.63561578944183]
  This paper proposes a novel Bayesian design, SDF-Bayes, for finding the maximum tolerated dose (MTD) of a drug in a clinical trial. Rather than the conventional principle of escalating or de-escalating the current dose of one drug, SDF-Bayes proceeds by cautious optimism. Extensive experiments based on both synthetic and real-world datasets demonstrate the advantages of SDF-Bayes over state of the art DC trial designs.
  arXiv  Detail & Related papers  (2021-01-26T18:59:26Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.